Research article · 12 Jun 2025
Research articlePublished 21 Jun 2023
Development and Clinical Validation of an HPLC-PDA Method for Imatinib Mesylate in Human Plasma: Interest in Therapeutic Drug Monitoring
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Imatinib is the first-line treatment for Chronic Myeloid Leukemia (CML), it has favorable pharmacokinetic properties, but resistance mechanisms may lead to diminished clinical response over time. Therapeutic Drug Monitoring targeting trough plasma concentrations may help to optimize the therapeutic effect, or there is a correlation between imatinib concentrations and treatment response. This study aimed to develop and validate a High-Performance Liquid Chromatographic method for the measurement of plasma concentrations of imatinib. The analyte was extracted from a 500µl plasma sampler and separated on a RESTEK C18 column (5 µm, 250 x 4.6 mm). Propranolol was used as an internal standard. The analytes were detected with a UV Photodiode Array Detector (PAD) at 270 nm. Linearity, accuracy, precision, recovery, selectivity, and Limit of Detection (LOD) and Limit of Quantification (LOQ) in the sample compartment were evaluated according to the International Conference on Harmonization bio analytical guidelines method guideline M10. The total run time was 7 min. The method appeared linear over a range from 0.2 to 10 µg/ml. Recovery was 98.2%-105%. The LOD and the LOQ were 200 ng/ml and 500 ng/ml, respectively. Our method appeared very suitable for therapeutic drug monitoring of imatinib. The developed method was fully validated. It is a simple, rapid, practical, and less expensive method to determine imatinib plasma concentrations in CML patients.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Deema Adawi”
- BylineArticles whose byline prints “Ichrack Dridi”
- BylineArticles whose byline prints “Mustafa Lubada”
- BylineArticles whose byline prints “Ahmad Al-barghouthi”
- BylineArticles whose byline prints “Ahlem Slama”
- BylineArticles whose byline prints “Hussein Hallak”
- BylineArticles whose byline prints “Karim Aouam”
